Success Stories: An Indian Senior Bioinformatics Scientist working in the Field of Bioinformatics Received O1-A as well as EB1-A Approvals with the expert advice of NAILG, Now Awaits NIW Approval
Client’s Testimonial:
“Thank you so much for your wishes! This approval would not have been possible without your help and expert guidance. Thank you for the time and effort spent on preparing and filing my case.”
On December 1st, 2021 and September 23rd, 2022, we received another O1-A (Individuals with Extraordinary Ability or Achievement) and EB-1A (Alien of Extraordinary Ability) approval for a Senior Bioinformatics Scientist in the Field of Bioinformatics (Approval Notice).
General Field: Bioinformatics
Position at the Time of Case Filing: Senior Bioinformatics Scientist
Country of Origin: India
State of Residence at the Time of Filing: Ohio
Approval Notice Date: December 1st, 2021 (O1-A) and September 23rd, 2022 (EB-1A)
Processing Time: 12 days (O1-A) (Premium Processing Requested) and 30 days (EB-1A) (Premium Processing Requested)
Case Summary:
While the O1-A visa benefits aliens of extraordinary ability in the sciences, arts, education, business, or athletics, those foreign nationals should at least have:
- Sustained national/international claim;
- Their achievement must be recognized in the field through extensive documentation;
- Current/previous employment in a critical or essential capacity for organizations or establishments that have a distinguished reputation.
- Evidence of original contributions, usually through publication, of major significance in the foreign national’s field of science, scholastic, artistic, or athletic;
- Receipt of a higher salary or remuneration than is usual in the field.
- Other comparable evidence if the above types of evidence do not readily apply to the foreign national’s occupation.
He is especially well-known for his work developing ARG-ANNOT, a bioinformatic tool for investigating antibiotic-resistance genes in bacterial genomes.
- His human microbiome and genomic alteration research address some of our nation’s and the world’s most pressing issues, including the investigation of microbiomes related to the development of numerous diseases, as well as the medical analysis of conditions such as giant cell arteritis, head, neck, breast cancer, and issues affecting the thoracic aorta.
- His work has resulted in 33 peer-reviewed scientific articles.
- His publications have been cited 1,853 times in at least 74 countries according to Google Scholar.
- He has completed at least 19 peer reviews.
“Along with the devastating loss of life associated with cancer, the disease imposes a significant economic burden on patients and on the nation as a whole…In order to mitigate the loss of life and the extreme economic burden placed on the country, the United States must prioritize the groundbreaking research that [client] is conducting and support him in his efforts to continue his research within the country.”
He acquired his O1-A visa approval in just 12 days (thanks to premium processing) and even received his EB1-A approval in a month. He has also retained our firm for his NIW approval. We wish him a flourishing life ahead and feel glad to have been a part of his fantastic journey.

